Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim report January – March 2024: Strong net rental income and continued expansion with the acquisition of our 100th property

In the first quarter of the year, our strong operational and financial progress continued as a result of annual rent increases, development projects, positive effects from completed acquisitions, and new and extended rental contracts with satisfied tenants.· Rental income increased by 24%, amounting to SEK 166 m (134). · Net operating income increased by 27%, amounting to SEK 137 m (108). · Profit from property management increased by 29% and amounted to SEK 89 m (69). · Earnings per share after dilution amounted to SEK 0.70 (0.22). · Net asset value (NAV) per share after

Outokumpu to close its Dahlerbrück and Hockenheim sites in Germany

Outokumpu CorporationPress releaseApril 24, 2024 at 9.00 EESTOutokumpu to close its Dahlerbrück and Hockenheim sites in Germany According to the company strategy, Outokumpu announced in November 2023 its plans on restructuring measures in Germany and started related procedures with employee representatives to shut down the operations of Dahlerbrück and Hockenheim sites in Germany. These negotiations have been completed in April 2024 with an agreement on the restructuring measures and execution of the closures can move forward. Outokumpu will now start to centralize advanced

Peab builds new main water and waste water pipelines in Nittedal

Peab has been commissioned to build new water and waste water pipelines in Nittedal. The customer is Nittedal Municipality and the contract is worth NOK 296 million.The project is a result of the requirement to reduce pollution of the Nitelva River by closing two local treatment plants. A power line will therefore be built to the central treatment plant and a new feeder line will be installed from the plant to Nittedal Municipality. The project includes construction of a more than ten kilometer stretch of the main water and waste water pipeline. The work will be carried out in areas

Genovis Annual Report 2023 published

Genovis 2023 Annual Report is now available in Swedish and English at our website.To read or download the annual report in Swedish, go to: https://investor.genovis.com/wp-content/uploads/Genovis_AR_2023_Sv.pdf To read or download the annual report in English, go to: https://investor.genovis.com/wp-content/uploads/Genovis_AR_2023_En.pdf For more information, please contact: Fredrik Olsson, CEO, Genovis AB T+46 (0)70 276 46 56 E:  fredrik.olsson@genovis.com

NOTICE OF ANNUAL GENERAL MEETING IN SAFETURE AB (PUBL)

The shareholders of SafetureAB (publ) reg. No. 556776-4674 (the “Company”) are hereby summoned to attend the Annual General Meeting (the “AGM”) on 28 May 2024 at 12.00 CEST at the Company’s premises, Kung Oscars väg 11C in Lund. Registration starts at 11.45 CEST.Right to participate Shareholders that wish to participate in the AGM shall be registered in the share register maintained by Euroclear Sweden AB no later than on 20 May 2024 and shall have notified the Company of their intention to participate at the AGM no later than on 22 May 2024. Notice to participate shall be given in

Inify Laboratories - More diagnoses delivered in the first quarter than in the whole of 2023

STOCKHOLM - April 24, 2024 - Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, saw a 184% increase in sales in Q1 2024, compared to the previous quarter. “What we see now is the result of many years of preparation. More diagnoses were delivered in the first quarter alone than in the whole of 2023. The company’s whole organization is ready for the significant increase in sales that we foresee both this year, and the years to come,” says CEO Fredrik Palm at Inify Laboratories. Inify is experiencing a great deal of interest from new

SciBase Partners with Al Shirawi Healthcare solutions to Offer Nevisense in UAE

STOCKHOLM, SWEDEN, - April 24, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies across multiple specialities of aesthetics dermatology, orthopedics and medical consumables In Dubai. Through this partnership, Nevisense will now be available for patients in the United Arab Emirates (UAE).Skin cancer is a growing problem in the UAE with official statistics suggesting that skin cancer

WELCOME TO THE EQT AB ANNUAL SHAREHOLDERS’ MEETING 2024

The shareholders of EQT AB (publ) (“EQT”) are given notice of the Annual Shareholders’ Meeting (the “Meeting”) to be held on Monday 27 May 2024 at 15.00 CEST at Cirkus, Djurgårdsslätten 43-45, SE-115 21 Stockholm, Sweden. Registration starts at 14.00 CEST. The shareholders may also choose to vote in advance.Conditions for participation Shareholders may choose to participate in, and vote at, the Meeting in person or in advance. Shareholders who wish to participate in the Meeting must be recorded in the share register maintained by Euroclear Sweden AB (“Euroclear”) concerning the

Pihlajalinna changes its segment reporting and provides comparative segment information for 2023

Pihlajalinna Plc         Stock Exchange Release         24 April 2024 at 9:00 a.m. Pihlajalinna changes its segment reporting and provides comparative segment information for 2023 Pihlajalinna will change its segment reporting from 1 January 2024. In the future, Pihlajalinna will have two reportable segments: Private Healthcare Services and Public Services. The new reporting structure follows Pihlajalinna’s business model and organisational structure. Private Healthcare Services operating segment consists of private clinic, diagnostics, hospital, occupational healthcare, remote and

Wallenstam’s interim report Jan–Mar 2024

Hans Wallenstam, CEO, and Susann Linde, CFO and Head of Investor Relations, comment on the report at www.wallenstam.se/filmsandpresentations. The film will be released by 08.30 (CEST) at the latest. An audiocast in English with Susann Linde will take place at 09.00 (CEST) at www.finwire.tv. The presentation is available at www.wallenstam.se/filmsandpresentations before 09.00 (CEST). January 1–March 31, 2024 · The equity/assets ratio amounted to 45 percent and the loan-to-value ratio was 46 percent. · Investment in new construction and reconstruction of properties amounted to SEK

News conference on Kojamo’s Interim Report for January–March 2024 on 8 May 2024

Kojamo plc Press Release, 24 April 2024 at 9:00 a.m. EESTNews conference on Kojamo’s Interim Report for January–March 2024 on 8 May 2024 Kojamo plc’s Interim Report for January–March 2024 will be published on Wednesday, 8 May 2024 at approximately 2:00 p.m. EEST. News conference Kojamo will hold a news conference for institutional investors, analysts and media on 8 May 2024 at 3:00 p.m. EEST at its headquarters at Mannerheimintie 168A, Helsinki, Finland. The event will be hosted by Kojamo’s CEO Jani Nieminen and CFO Erik Hjelt, and it will be held in English. After the event, the

NIB finances new central hospital in Hämeenlinna

The Nordic Investment Bank (NIB) and the Wellbeing Services County (WSC) of Kanta-Häme have signed a 25-year uncommitted credit facility for the new central hospital in Hämeenlinna, Finland.NIB’s financing of up to EUR 100 million supports the construction of the 97,000-square-metre Assi facility in the current hospital campus in Ahvenisto. The new building will facilitate 390 hospital beds, have a work force of around 1,900 and is expected to accommodate around 211,000 visitors from the Kanta-Häme region annually. The new hospital will modernise treatment processes, enhance logistics,

Interim Report 1 January – 31 March 2024

Positive profitability trend driven by Medtech "During the quarter, profitability strengthened in line with our priorities and organic sales increased by 4%. Labtech's sales performance was temporarily weaker, but the companies were largely able to defend their margins. Medtech delivered strong growth and it is gratifying to see a gradual improvement in profitability, driven in part by implemented improvement measures."Fredrik Dalborg, President and CEO AddLife´s interim report for Q1 2024 is now available online at the company website. The interim report can be downloaded in pdf

Interim report January 1 – March 31, 2024

Stronger operating income and strategically niched acquisitionsJanuary 1 - March 31 · Net sales amounted to SEK 1,736 m (1,877), corresponding to a 7.5% decrease in sales. At fixed exchange rates, net sales decreased by 7.5%. · The gross profit amounted to SEK 435 m (391), an increase of 11.2% in absolute terms compared with the same period last year. The gross margin increased by 4.2 percentage points. · Operating income amounted to SEK 140 m (130), corresponding to an increase of 7.6% compared with the same period last year. · Continued expansion in the field of sustainable,

Storebrand Boligkreditt AS: Interim Report Q1 2024

Storebrand Boligkreditt AS is a wholly owned subsidiary of the listed company Storebrand ASA. For information about the Storebrand Group's Q1 2024 result and balance sheet statement, please refer to the Storebrand Group Q1 2024 interim report. Storebrand Boligkreditt AS's interim report for Q1 2024 is attached.This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

Storebrand Livsforsikring AS: Interim Report Q1 2024

Storebrand Livsforsikring AS is a wholly owned subsidiary of the listed company Storebrand ASA. For information about the Storebrand Group's Q1 2024 result and Balance sheet statement, please refer to the Storebrand Group Q1 2024 interim report. Storebrand Livsforsikring AS's interim report for Q1 2024 is attached.This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

Panoro Energy – 2023 Annual Statement of Reserves

Oslo, 24 April 2024 – Panoro Energy ASA (“Panoro” or the “Company”) is pleased to announce the release of its 2023 Annual Statement of Reserves (the “ASR”). Highlights Panoro’s total net working interest reserves as of 31 December 2023 were: Proved (1P) reserves of 23.22 MMbbls (31 December 2022: 23.41 MMbbls) Proved + probable (2P) reserves of 34.67 MMbbls (31 December 2022: 35.61 MMbbls) Proved + Probable + Possible (3P) reserves of 46.52 MMbbls (31 December 2022: 48.65 MMbbls) The year-on-year movement in Panoro’s 2P reserves at 31 December 2023 reflects production in

Panoro Energy – Publication of 2023 Annual Report and Sustainability Report

Oslo, 24 April 2024 – Panoro Energy ASA (“Panoro” or the “Company” with OSE ticker: PEN) has today published its Annual Report and Accounts for the financial year ended 31 December 2023. The report is attached in the European Single Electronic Format (ESEF) and as a PDF file which is also available on the Company's website www.panoroenergy.com. Panoro has also today published its Sustainability Report for the year 2023. The report outlines Panoro’s sustainability strategy, performance and progress towards achieving its goals and is available on the Company’s website www.panoroenergy.

Scandic’s interim report for the first quarter 2024 – Stable start to the year and good booking situation for the second quarter

First quarter in summary, January 1 – March 31, 2024. · Net sales declined by 2.4 percent to 4,419 million SEK (4,526). The 2024 Easter holiday occurred in March, which is why the quarter is not fully comparable with the first quarter 2023. Calendar effects are estimated to have impacted net sales negatively by 4 to 5% due to the early Easter. · Average occupancy rate was 51.9 percent (53.5). · Average revenue per available room (RevPAR) was 619 SEK (626). · Operating profit totaled 126 million SEK (199). · Adjusted EBITDA was 33 million SEK (170). · Excluding IFRS 16,

Bonava’s interim report for the first quarter 2024: Improved sales to consumers and net debt halved

First quarter, January – March 2024*:   · Net sales amounted to SEK 1,280 M (1,929) · Gross margin amounted to 10.4 per cent (8.8) · Operating profit amounted to SEK -22 M (-28) and operating margin was -1.7 per cent (-1.4) · Cash flow before financing activities amounted to SEK -483 M (-963) · Earnings per share, before and after dilution, was SEK -0.87 (-0.85) · The number of housing units sold to consumers was 302 (203) · The number of housing units sold to investors was 0 (75) · The number of production starts was 281 (334)   *Recognised revenue and

Skanska signs contract regarding manufacturing facility in the Northeast USA for USD 94M, about SEK 970M

Skanska has signed a construction contract with a consumer goods manufacturer regarding a manufacturing facility in the Northeast region of the USA. The contract is worth USD 94M, about SEK 970M, which will be included in the US order bookings for the second quarter of 2024.Work will include renovation and addition to an existing manufacturing facility. Work will begin in the second quarter of 2024 and is anticipated to be completed in 2025.

Evolution: Interim report January-March 2024

First quarter of 2024 (Q1 2023) · Operating revenues increased by 16.7% to EUR 501.5 million (429.6) · EBITDA increased by 15.2% to EUR 345.8 million (300.2), corresponding to a margin of 69.0% (69.9) · Profit for the period amounted to EUR 269.2 million (251.2) · Earnings per share before dilution amounted to EUR 1.27 (1.18) Comments from CEO Martin Carlesund: For the first quarter of 2024, Evolution continued to render strong results. Revenue amounted to EUR 501.5 million (429.6) corresponding to year-on-year revenue growth of 16.7 percent with an EBITDA margin of 69.0

Kindred Group plc – Interim report: January – March 2024 (unaudited)

Solid start to a transformational year Kindred Group plc – Interim report: January – March 2024 (unaudited)First quarter 2024 · Total revenue was GBP 307.7 (306.4) million, in line with the first quarter of 2023. · Gross winnings revenue (B2C) was GBP 297.6 (297.3) million. · Underlying EBITDA increased by 20 per cent to GBP 59.3 (49.4) million. · Profit before tax was GBP 39.8 (30.4) million. · Profit after tax was GBP 31.4 (25.6) million. · Earnings per share were GBP 0.15 (0.12). · Free cash flow amounted to GBP 23.7 (29.0) million. · Number of active

Electrolux Professional AB interim report Q1 2024

First quarter, January-March 2024· Net sales amounted to SEK 3,055m (2,968), an increase of 2.9%. Organically, sales decreased by 4.3%. TOSEI contributed by 8.1%. Currency translation had a negative effect of 0.9%. · EBITA amounted to SEK 326m (340), corresponding to a margin of 10.7% (11.4). EBITA includes integration related costs for TOSEI of SEK 38m. Excluding integration related costs, the underlying EBITA would have been SEK 364m, and the EBITA margin 11.9%. · Operating income amounted to SEK 271m (301), corresponding to a margin of 8.9% (10.1). · Income for the period

There are no items matching the current filter
There are no more items matching the current filter
Back to top